Captix Biomedical Pty Ltd – Trademark Portfolio

Entity Type: 99

Captix Biomedical Pty Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IMITA and CAPTIXBIO.

c/- Integra Law,

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IMITA
IMITA
Registered 2020
CAPTIXBIO
CAPTIXBIO
Registered 2020

Trademark Classifications

Captix Biomedical Pty Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Captix Biomedical Pty Ltd have?

Captix Biomedical Pty Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Captix Biomedical Pty Ltd file in?

Captix Biomedical Pty Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Captix Biomedical Pty Ltd's most well-known trademarks?

Captix Biomedical Pty Ltd's registered trademark portfolio includes well-known marks such as IMITA and CAPTIXBIO. These are among 2 currently registered trademarks in the portfolio.

What is Captix Biomedical Pty Ltd's trademark registration success rate?

Captix Biomedical Pty Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.